Dr. Rick Bright has been appointed the Rockefeller Foundation as senior vice president of Pandemic Prevention and Response, with responsibilities including leading pandemic prevention institute development.
“We are thrilled to have someone of Rick’s caliber join The Rockefeller... Read More »
A new deal reached between Baxter BioPharma Solutions and Moderna, Inc. this week will see Baxter handle fill/finish services for Moderna’s COVID-19 vaccine in the United States, ultimately providing between 60-90 million doses this year.
Baxter’s Indiana facility will handle the... Read More »
Nuclear Threat Initiative (NTI) officials indicated its recent Global Biosecurity Dialogue resulted in participants pledging to take 12 specific actions to advance global biosecurity along with eight jointly developed priority areas.
More than 170 government officials, health and biosecurity... Read More »
A molecular test for COVID-19 can now be used at home without a prescription, following the U.S. Food and Drug Administration’s (FDA) granting of emergency use authorization (EUA) to the Cue COVID-19 Test for Home and Over the Counter (OTC) Use.
A molecular nucleic acid amplification test... Read More »
The preliminary results of a Phase 2a randomized, double-blind trial of the Merck and Ridgeback Biotherapeutics-created oral antiviral for the treatment of COVID-19, molnupiravir, have shown the ability to quickly decrease the infectious virus among patients.
While full results are pending, this... Read More »
Through a deal between the World Health Organization and others with GSK, a rotavirus vaccine will be available to more children living in low-income nations facing humanitarian crises.
The agreement makes use of the multi-partner Humanitarian Mechanism, launched in 2017, where manufacturers... Read More »
Lockheed Martin is touting the successful testing of its next-generation Extended-Range Guided Multiple Launch Rocket System (ER GMLRS) munition via an 80-kilometer flight demonstration at White Sands Missile Range.
“Our new Extended-Range GMLRS significantly increases the range of the... Read More »
New research from the Washington University School of Medicine in St. Louis seemingly confirms scientists' and health experts' worst fear that all three of the prominent, fast-spreading variants of COVID-19 can resist vaccines and antibodies currently effective against their forebear.
Published... Read More »
Under a new agreement, Novartis will manufacture the mRNA and bulk drug product for CureVac’s CVnCoV vaccine candidate for COVID-19, with a goal of up to 50 million doses by the end of 2021.
“I am very pleased that with Novartis, we have found another highly experienced partner to support... Read More »
Research from Battelle shows that wastewater analysis can pinpoint neighborhoods that are hotspots for viral outbreaks of COVID-19.
A preliminary report was preprinted on Feb. 20 in the MedRxIv found that by testing wastewater for the presence of SARS-COV-2 and other pathogens, they were able... Read More »
In a new study published on bioRxiv, Soligenix, Inc. reported that its CiVax COVID-19 vaccine demonstrated rapid, broad-spectrum, neutralizing antibody and immunity onset in preclinical studies.
The head stable vaccine used full-length Spike protein antigens to do its work, and at least in... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Hologic, Inc. are working together to develop the Panther Fusion SARS-CoV-2/Flu/RSV assay, intended to be able to simultaneously detect and differentiate a variety of viruses from a single sample.
While SARS-CoV-2 is a major... Read More »
The U.S. Department of Homeland Security’s (DHS) Science and Technology Directorate (S&T) Silicon Valley Innovation Program (SVIP) announced Tuesday that it would be awarding $196,880 to fund a video analytics program for the Transportation Security Administration (TSA).
The funding was... Read More »
The biopharmaceutical company AstraZeneca said it has initiated steps to provide broad and equitable access to the COVID-19 vaccine, noting doses have begun arriving globally in low and middle-income countries.
“These first steps towards fulfilling our broad, equitable, and no-profit emergency... Read More »
A Study of Terrorism and Responses to Terrorism (START) report examining extremism has determined QAnon escalated from an obscure fringe group to a mainstream movement, but few have committed crimes.
START researchers at the University of Maryland compiled QAnon supporter data regarding those... Read More »
A team, including GE Research, the Broad Institute, DNA Script, MEDInstill, Molecular Assemblies, and the University of Washington, has been awarded a five-year, up to $41 million contract from the Defense Advanced Research Projects Agency (DARPA) to create a new, quicker vaccine production... Read More »
In what Johnson & Johnson CEO Alex Gorsky called a great example for the larger pharmaceutical industry, the company has reached a deal with fellow pharmaceutical giant and oft-rival Merck that will unite the pair’s resources to produce Johnson & Johnson’s new COVID-19 vaccine.
Faced... Read More »
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) awarded up to $18 million to GSK Biologicals and its affiliate GSK Vaccines Institute for Global Health (GVGH) to develop new vaccines for two different illnesses.
One is a vaccine for Group A streptococcus... Read More »
The National Institutes of Health (NIH) has earmarked funding totaling nearly $33 million over four years for five University of California San Diego Rapid Acceleration of Diagnostics (RADx) projects.
The RADx initiative seeks to expedite the development, commercialization, and implementation of... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) recently partnered with LightDeck Diagnostics to create a six-minute SARS-CoV-2 antigen test usable without the need for a full diagnostic laboratory.
This point of care test could be used for on-site screening of suspected... Read More »
The U.S. Food and Drug Administration (FDA) granted emergency use authorization Monday for the Quidel QuickVue At-Home COVID-19 Test.
An antigen test, QuickVue will allow users suspected of having COVID-19 by their healthcare provider within the first six days of symptom onset to quickly collect... Read More »
Lawmakers representing the Committee on Oversight and Reform and Committee on Homeland Security recently conducted joint hearings to examine potential actions after cybersecurity incidents impacting government and private sector networks.
The panels detailed the supply chain attacks targeting... Read More »
The United States will now benefit from the rollout of a third COVID-19 vaccine, following last week’s emergency use authorization (EUA) of the Janssen vaccine by the U.S. Food and Drug Administration (FDA).
That decision came in the wake of recommendations from an advisory panel known as the... Read More »
A new report from Johns Hopkins Center for Health Security found that emergency departments in New York City hospitals were overwhelmed and struggled to maintain conventional standards of care during the COVID-19 pandemic.
The report, “Crisis Standards of Care: Lessons from New York City... Read More »
Regeneron Pharmaceuticals is making changes to the Phase 3 trial of its Regen-COV treatment for outpatients with COVID-19.
The changes come at the recommendation of the Independent Data Monitoring Committee (IDMC), which said to no longer use a placebo group in the trial. IDMC found clear... Read More »
Pfizer Inc. and BioNTech announced the beginning of an evaluation into the safety and immunogenicity of a third dose of their COVID-19 vaccine last week to study the effects of a booster vaccine against emerging SARS-CoV-2 variants.
This will be offered to up to 144 participants from the phase... Read More »
The first 600,000 doses of the AstraZeneca/Oxford COVID-19 vaccine allocated to the COVAX Facility have been delivered to Ghana, with further deliveries expected to reach Cote d’Ivoire later this week.
It marks the beginning of a global rollout long in the planning and the first COVAX vaccine... Read More »
According to a new study from the National Cancer Institute (NCI), at least a few months of protection may be granted against reinfection to those with SARS-CoV-2.
As part of the National Institutes of Health, NCI worked with healthcare data analytics companies HealthVerity and Aetion, Inc. and... Read More »
The Navy and Air Force have awarded Lockheed Martin a $414 million contract for Long Range Anti-Ship Missile (LRASM) production.
The agreement represents the largest LRASM production pact in the program's history. The combined Lot 4/5 contract continues production of the air-launched variant of... Read More »
A group of lawmakers recently forwarded correspondence to Facebook CEO Mark Zuckerberg, seeking insight regarding the company’s alleged role in knowingly allowing extremist content and groups growth on its platform.
Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Oversight... Read More »
A Phase 1B clinical trial of Lassa fever vaccine INO-4500, developed by INOVIO, began dosing its first patient this week in Ghana.
The vaccine is a first on several fronts: the first candidate for Lassa fever to begin human trials and the first to have trials conducted in West Africa, where the... Read More »
A pair of monoclonal antibodies (mAbs) developed by Regeneron have shown promising signs against the coronavirus that causes Middle East respiratory syndrome (MERS) in a phase one clinical trial that marked the first such test conducted on people.
In all, the National Institute of Allergy and... Read More »
Specialty vaccine company Valneva has initiated a Phase 3 study for its single-shot chikungunya vaccine candidate, VLA1553.
VLA1553 is the only chikungunya vaccine candidate in Phase 3 clinical trials. Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV).... Read More »
In an effort to meet global supply demands, Sanofi has agreed to support the manufacturing of a COVID-19 vaccine made by Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., both of which are part of Johnson & Johnson.
The Janssen candidate has been submitted to the U.S. Food and Drug... Read More »
Five COVID-19 vaccine manufacturers assured Congress Tuesday that they are closely watching the emergence of new variants of COVID-19 and are optimistic the two vaccines currently approved in the United States and a third poised for approval will treat those new variants that have emerged in the... Read More »